Dream suppression: Difference between revisions
>Graham m Grammatics |
>Graham m New reference format |
||
Line 2: | Line 2: | ||
'''Dream suppression''' is a decrease in the vividness, intensity, frequency, and recollection of a person's dreams. At its lower levels, this can be a partial suppression which results in the person having dreams of a lesser intensity and a lower rate of frequency. However, at its higher levels, this can be a complete suppression which results in the person not experiencing any dreams at all. | '''Dream suppression''' is a decrease in the vividness, intensity, frequency, and recollection of a person's dreams. At its lower levels, this can be a partial suppression which results in the person having dreams of a lesser intensity and a lower rate of frequency. However, at its higher levels, this can be a complete suppression which results in the person not experiencing any dreams at all. | ||
Dream suppression is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[cannabinoid|cannabinoids]]<ref name=" | Dream suppression is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[cannabinoid|cannabinoids]]<ref name="SchierenbeckRiemann2008">{{cite journal|last1=Schierenbeck|first1=Thomas|last2=Riemann|first2=Dieter|last3=Berger|first3=Mathias|last4=Hornyak|first4=Magdolna|title=Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana|journal=Sleep Medicine Reviews|volume=12|issue=5|year=2008|pages=381–389|issn=10870792|doi=10.1016/j.smrv.2007.12.004}}</ref> and most types of antidepressants<ref name="SharpleyCowen1995">{{cite journal|last1=Sharpley|first1=Ann L.|last2=Cowen|first2=Philip J.|title=Effect of pharmacologic treatments on the sleep of depressed patients|journal=Biological Psychiatry|volume=37|issue=2|year=1995|pages=85–98|issn=00063223|doi=10.1016/0006-3223(94)00135-P}}</ref><ref name="Trivedi1999">{{cite journal|last1=Trivedi|first1=M|title=Effects of Fluoxetine on the Polysomnogram in Outpatients with Major Depression|journal=Neuropsychopharmacology|volume=20|issue=5|year=1999|pages=447–459|issn=0893133X|doi=10.1016/S0893-133X(98)00131-6}}</ref><ref name="VogelBuffenstein1990">{{cite journal|last1=Vogel|first1=G.W.|last2=Buffenstein|first2=A.|last3=Minter|first3=K.|last4=Hennessey|first4=Ann|title=Drug effects on REM sleep and on endogenous depression|journal=Neuroscience & Biobehavioral Reviews|volume=14|issue=1|year=1990|pages=49–63|issn=01497634|doi=10.1016/S0149-7634(05)80159-9}}</ref>. This is due to the way in which they increase REM latency, decrease REM sleep, reduce total sleep time and efficiency, and increase [[wakefulness]].<ref name="SchierenbeckRiemann2008"/><ref name="SharpleyCowen1995"/><ref name="Trivedi1999"/><ref>Feinberg, I., Jones, R., Walker, J. M., Cavness, C., & March, J. (1975). Effects of high dosage delta‐9‐tetrahydrocannabinol on sleep patterns in man. Clinical Pharmacology & Therapeutics, 17(4), 458-466. https://www.ncbi.nlm.nih.gov/pubmed/164314</ref> REM sleep is where the majority of dreams occur.<ref>Hobson, J. A., Stickgold, R., & Pace-Schott, E. F. (1998). The neuropsychology of REM sleep dreaming. Neuroreport, 9(3), R1-R14. https://www.ncbi.nlm.nih.gov/pubmed/9512371</ref> | ||
</onlyinclude> | </onlyinclude> | ||
===Psychoactive substances=== | ===Psychoactive substances=== |